Found 404 clinical trials
Chronic Heart Failure - COngestion eValuation (CHF-COV)
Heart failure (HF) is a significant cause of death and the leading cause of hospitalization in patients over 65 years of age. Congestion is the main source of symptoms and the leading cause of
- 0 views
- 09 Jul, 2022
- 1 location
Acute Heart Failure - COngestion Discharge Evaluation (AHF-CODE)
congestion assessed by implantable devices (not reimbursed in France) improves the prognosis. However, due to the lack of a standardised congestion assessment, therapeutic adaptation in acute heart failure
- 0 views
- 23 Mar, 2022
- 1 location
Acute Heart Failure - COngestion Repeated Evaluation (AHF-CORE) (AHF-CORE)
The AHF-CORE study is a prospective, non-randomized, multicenter regional study. The main objective of the AHF-CORE study is to identify congestion markers (clinical, biological and
- 7 views
- 04 Oct, 2022
- 2 locations
Acute Heart Failure With Reduced Ejection Fraction - COngestion Discharge Evaluation
> The main objective of the AHF-CODE study is to identify congestion markers (clinical, biological and ultrasound) at the end of hospitalization for acute heart failure that are associated with the risk
- 6 views
- 30 Jan, 2021
- 1 location
Acute Heart Failure With Preserved Ejection Fraction - COngestion Discharge Evaluation
. The main objective of the AHF-CODE preserved study is to identify congestion markers (clinical, biological and ultrasound) at the end of hospitalization for acute heart failure that are
- 12 views
- 02 Feb, 2021
- 1 location
A Nasal Spray for Relief of Nasal Congestion in Infants and Toddlers With Common Cold
The study will evaluate the safety and efficacy of the study medical device plus standard of care versus standard of care in subjects between 3 and 48 months (inclusive) presenting symptoms of a common cold.
- 0 views
- 30 May, 2022
- 1 location
Efficacy and Safety of Azeol Nasal Spray Versus Placebo in the Treatment of Early Symptoms of Common Cold in Adults
The main objective is to evaluate the efficacy of Azéol Spray Nasal, taken two times a day, versus placebo on nasal congestion in subject with common cold.
- 0 views
- 22 Dec, 2021
- 1 location
Fibrosis and the Fontan
the response to acute imposition of Fontan hemodynamics by examining the interrelationship between liver and cardiac fibrosis/dysfunction and lymphatic congestion along with a pilot trial of the
- 0 views
- 04 Jun, 2021
- 1 location
Splanchnic Nerve Block for Therapy of Chronic Heart Failure (Splanchnic III)
cardiac congestion in patients presenting with HF. Based on preliminary safety and efficacy data in acute and chronic heart failure patients with temporary (<24 h) SNB. Now we will apply a prolonged
- 0 views
- 30 Nov, 2021
- 1 location
Impella CP With VA ECMO for Cardiogenic Shock (REVERSE)
congestion, which can derail clinical improvement and hamper cardiac recovery. Indeed, percutaneous VA-ECMO increases LV afterload due to the retrograde blood flow, and because of the lack of venting, there
- 12 views
- 03 Mar, 2022
- 1 location